{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:55:24Z","timestamp":1778824524816,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K16673"],"award-info":[{"award-number":["JP22K16673"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11060-023-04473-6","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:01:57Z","timestamp":1697191317000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Residual diffusion-weighted imaging hyperintense signal in primary central nervous system lymphoma can predict early recurrence"],"prefix":"10.1007","volume":"165","author":[{"given":"Shumpei","family":"Onishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiyuki","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishwa Jeet","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Takayasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ushio","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iori","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Novita Ikbar","family":"Khairunnisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"4473_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C et al (2022) CBTRUS Statistical Report: primary brain and other Central Nervous System Tumors diagnosed in the United States in 2015\u20132019. Neuro Oncol 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro Oncol"},{"key":"4473_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/neuonc\/nox187","volume":"20","author":"JS Mendez","year":"2018","unstructured":"Mendez JS, Ostrom QT, Gittleman H et al (2018) The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades. Neuro Oncol 20:687\u2013694. https:\/\/doi.org\/10.1093\/neuonc\/nox187","journal-title":"Neuro Oncol"},{"key":"4473_CR3","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey LE, Batchelor TT, Ferreri AJM et al (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034\u20135043.\u00a0https:\/\/doi.org\/10.1200\/JCO.2005.13.524","journal-title":"J Clin Oncol"},{"key":"4473_CR4","doi-asserted-by":"publisher","first-page":"e071350","DOI":"10.1136\/bmjopen-2022-071350","volume":"13","author":"F Yamasaki","year":"2023","unstructured":"Yamasaki F, Fudaba H, Asano K et al (2023) Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study. BMJ Open 13:e071350. https:\/\/doi.org\/10.1136\/bmjopen-2022-071350","journal-title":"BMJ Open"},{"key":"4473_CR5","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S1470","volume":"11","author":"L Plasswilm","year":"2010","unstructured":"Plasswilm L, Bamberg M, Thiel E et al (2010) Articles high-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncol 11:1036\u20131083. https:\/\/doi.org\/10.1016\/S1470","journal-title":"Lancet Oncol"},{"key":"4473_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ana.20495","volume":"57","author":"U Herrlinger","year":"2005","unstructured":"Herrlinger U, K\u00fcker W, Uhl M et al (2005) NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report. Ann Neurol 57:843\u2013847. https:\/\/doi.org\/10.1002\/ana.20495","journal-title":"Ann Neurol"},{"key":"4473_CR7","doi-asserted-by":"publisher","unstructured":"Omuro A, Correa DD, Deangelis LM et al (2015) R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma key points. https:\/\/doi.org\/10.1182\/blood-2014","DOI":"10.1182\/blood-2014"},{"key":"4473_CR8","doi-asserted-by":"publisher","unstructured":"van der Meulen M, Postma AA, Smits M et al (2021) Extent of radiological response does not reflect survival in primary central nervous system lymphoma. Neurooncol Adv 3:vdab007. https:\/\/doi.org\/10.1093\/noajnl\/vdab007","DOI":"10.1093\/noajnl\/vdab007"},{"key":"4473_CR9","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/neuonc\/nov095","volume":"17","author":"BM Ellingson","year":"2015","unstructured":"Ellingson BM, Bendszus M, Boxerman J et al (2015) Consensus recommendations for a standardized brain tumor imaging protocol in clinical trials. Neuro Oncol 17:1188\u20131198.\u00a0https:\/\/doi.org\/10.1093\/neuonc\/nov095","journal-title":"Neuro Oncol"},{"key":"4473_CR10","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/neuonc\/noab020","volume":"23","author":"RF Barajas","year":"2021","unstructured":"Barajas RF, Politi LS, Anzalone N et al (2021) Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: Guideline statement from the International Primary CNS lymphoma Collaborative Group (IPCG). Neuro Oncol 23:1056\u20131071. https:\/\/doi.org\/10.1093\/neuonc\/noab020","journal-title":"Neuro Oncol"},{"key":"4473_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1148\/radiol.2241010637","volume":"224","author":"AC Guo","year":"2002","unstructured":"Guo AC, Cummings TJ, Dash RC, Provenzale JM (2002) Lymphomas and High-Grade Astrocytomas: comparison of Water Diffusibility and histologic characteristics. Radiology 224:177\u2013183. https:\/\/doi.org\/10.1148\/radiol.2241010637","journal-title":"Radiology"},{"key":"4473_CR12","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1148\/radiol.2353031338","volume":"235","author":"F Yamasaki","year":"2005","unstructured":"Yamasaki F, Kurisu K, Satoh K et al (2005) Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 235:985\u2013991.\u00a0https:\/\/doi.org\/10.1148\/radiol.2353031338","journal-title":"Radiology"},{"key":"4473_CR13","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1158\/1078-0432.CCR-11-0625","volume":"18","author":"MJ Wieduwilt","year":"2012","unstructured":"Wieduwilt MJ, Valles F, Issa S et al (2012) Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res 18:1146\u20131155. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0625","journal-title":"Clin Cancer Res"},{"key":"4473_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3174\/ajnr.A1750","volume":"31","author":"RF Barajas","year":"2010","unstructured":"Barajas RF, Rubenstein JL, Chang JS et al (2010) Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. Am J Neuroradiol 31:60\u201366. https:\/\/doi.org\/10.3174\/ajnr.A1750","journal-title":"Am J Neuroradiol"},{"key":"4473_CR15","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3174\/ajnr.A4867","volume":"37","author":"WY Huang","year":"2016","unstructured":"Huang WY, Wen JB, Wu G et al (2016) Diffusion-weighted imaging for predicting and monitoring primary central nervous system lymphoma treatment response. Am J Neuroradiol 37:2010\u20132018. https:\/\/doi.org\/10.3174\/ajnr.A4867","journal-title":"Am J Neuroradiol"},{"key":"4473_CR16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/neuonc\/now238","volume":"19","author":"E Tabouret","year":"2017","unstructured":"Tabouret E, Houillier C, Martin-Duverneuil N et al (2017) Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial. Neuro Oncol 19:422\u2013429. https:\/\/doi.org\/10.1093\/neuonc\/now238","journal-title":"Neuro Oncol"},{"key":"4473_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11060-010-0287-5","volume":"102","author":"L Fischer","year":"2011","unstructured":"Fischer L, Koch A, Schlegel U et al (2011) Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions. J Neurooncol 102:163\u2013166. https:\/\/doi.org\/10.1007\/s11060-010-0287-5","journal-title":"J Neurooncol"},{"key":"4473_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/emmm.201404055","volume":"6","author":"D Le Bihan","year":"2014","unstructured":"Le Bihan D (2014) Diffusion MRI: what water tells us about the brain. EMBO Mol Med 6:569\u2013573. https:\/\/doi.org\/10.1002\/emmm.201404055","journal-title":"EMBO Mol Med"},{"key":"4473_CR19","doi-asserted-by":"publisher","unstructured":"Schob S, Meyer J, Gawlitza M et al (2016) Diffusion-weighted MRI reflects proliferative activity in primary CNS lymphoma. PLoS ONE 11. https:\/\/doi.org\/10.1371\/journal.pone.0161386","DOI":"10.1371\/journal.pone.0161386"},{"key":"4473_CR20","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/neuonc\/nov197","volume":"18","author":"C Izquierdo","year":"2016","unstructured":"Izquierdo C, Velasco R, Vidal N et al (2016) Lymphomatosis cerebri: a rare form of primary central nervous system lymphoma. Analysis of 7 cases and systematic review of the literature. Neuro Oncol 18:707\u2013715.\u00a0https:\/\/doi.org\/10.1093\/neuonc\/nov197","journal-title":"Neuro Oncol"},{"key":"4473_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40644-017-0128-2","volume":"17","author":"H Yu","year":"2017","unstructured":"Yu H, Gao B, Liu J et al (2017) Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features. Cancer Imaging 17:26. https:\/\/doi.org\/10.1186\/s40644-017-0128-2","journal-title":"Cancer Imaging"},{"key":"4473_CR22","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.ejrad.2011.05.028","volume":"81","author":"G Schulte-Altedorneburg","year":"2012","unstructured":"Schulte-Altedorneburg G, Heuser L, Pels H (2012) MRI patterns in recurrence of primary CNS lymphoma in immunocompetent patients. Eur J Radiol 81:2380\u20132385. https:\/\/doi.org\/10.1016\/j.ejrad.2011.05.028","journal-title":"Eur J Radiol"},{"key":"4473_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-017-0064-3","author":"P Ambady","year":"2017","unstructured":"Ambady P, Fu R, Netto JP et al (2017) Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease. Fluids Barriers CNS. 14:16.\u00a0https:\/\/doi.org\/10.1186\/s12987-017-0064-3","journal-title":"Fluids Barriers CNS"},{"key":"4473_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11060-020-03446-3","volume":"147","author":"MP Patel","year":"2020","unstructured":"Patel MP, Kirkpatrick JP, Johnson MO et al (2020) Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series. J Neurooncol 147:477\u2013483. https:\/\/doi.org\/10.1007\/s11060-020-03446-3","journal-title":"J Neurooncol"},{"key":"4473_CR25","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1200\/JCO.2013.50.4910","volume":"31","author":"PG Morris","year":"2013","unstructured":"Morris PG, Correa DD, Yahalom J et al (2013) Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31:3971\u20133979. https:\/\/doi.org\/10.1200\/JCO.2013.50.4910","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04473-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04473-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:10:45Z","timestamp":1699614645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04473-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["4473"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04473-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or nonfinancial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective study was approved by our Institutional Review Board, and the requirement for informed consent was waived because of the retrospective nature of this study (approval no. E2022-0038).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}